Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Smith & Wesson Brands发布疲软的第四季度业绩，加入Aptevo Therapeutics和其他大股票，在周五的盘前交易中下跌。
U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Friday.
美国股票期货今晨下跌，道琼斯期货周五下跌约0.2%。
Shares of Smith & Wesson Brands Inc (NASDAQ:SWBI) fell sharply in pre-market trading after the company reported worse-than-expected fourth-quarter EPS and sales.
Smith & Wesson Brands Inc（纳斯达克：SWBI）的股票在美股盘前交易中大幅下跌，原因是公司公布的第四季度每股收益和营收均低于预期。
Smith & Wesson Brands reported fourth-quarter revenue of $140.8 million, missing analyst estimates of $152.41 million, according to Benzinga Pro. The company reported adjusted earnings of 20 cents per share in the fourth quarter, missing estimates of 23 cents per share.
Smith & Wesson Brands公布第四季度营业收入为14080万美元，低于分析师预期的15241万美元，数据来源于Benzinga Pro。该公司报告第四季度调整后每股收益为20美分，低于预期的23美分。
Smith & Wesson Brands shares dipped 12.6% to $9.51 in the pre-market trading session.
Smith & Wesson Brands的股票在美股盘前交易中下跌了12.6%，至9.51美元。
Here are some other stocks moving...
以下是一些在...
登录免费看全文
登录/注册
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
